The LDL level where you would empirically start a statin.
What is 190
The blood pressure at which the AHA/ACC guidelines say is stage I HTN
SBP 130-139mmHg
DBP 80-89mmHg
The duration of anticoagulation for an unprovoked VTE
What is indefinite (for males) and indefinite or shorter for females at low risk based on the HerDoo2 risk stratification system
The clinical syndrome of heart failure
The 10 year ASCVD risk level that is high risk
What is >=20%
The amount of exercise in time recommended for first line lifestyle recommendations
The risk prediction tool to assess pre-test probability of VTE
What is the Well's Criteria
The class of heart failure with an ejection fraction 40-50%
What is heart failure with improving or recovering ejection fraction
The class of heart failure when a patient is experiencing marked limitations of physical activity
What is Class III
The age that you should consider discontinuing a statin
The first line treatment for older adults with hypertension
What is a thiazide diuretic
Absolute contraindication for treatment with direct oral anticoagulants
What is mechanical valve or severe renal insufficiency GFR <15
What is Sacubitril-Valsartan
The stage of heart failure where there is structural heart disease but no symptoms
What is Stage B
The LDL level that a person with diabetes with an age range of 40-75 should be treated with statin
What is an LDL of 70-189
What is >180 and/or >120 with target end organ damage
The situation in which no bridging therapy is needed for initiation of anticoagulation of VTE
What when there has been no prior VTE or last VTE was >3 months ago without additional risk factors (i.e. active cancer)
Angiotensin Receptor - Neprolysin Inhibitor or ARNI for short
The medication that should not be administered for persons with a history of angioedema or administered within 36 hours of an ACE inhibitor
Name 3 ASCVD risk enhancers by history (there are 7)
-Family history of premature ASCVD
-Chronic kidney disease
-Metabolic syndrome
-Conditions specific to women (preeclampsia, premature menopause)
-Inflammatory diseases (especially rheumatoid, psoriasis, HIV)
-Ethnicity (South Asian)
The finding of the SPRINT trial
The finding of the PREPIC2 Study
What is that routine placement of retrievable IVC filters does not reduce the risk of recurrent PE compared to anticoagulation
The medication class has shown NO benefit for the treatment of heart failure stage C with preserved EF
Phosphodiesterase-5 inhibitors
The medication that can be prescribed for heart failure stage C with preserved ejection fraction (in the appropriate population)
What is aldosterone receptor antagonist (spironolactone or eplerenone)